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ABSTRACT
Background Effective condom use can prevent sexually
transmitted infections (STIs) and unwanted pregnancy.
We conducted a systematic review and methodological
appraisal of randomised controlled trials (RCTs) of
interventions to promote effective condom use.
Methods We searched for all RCTs of interventions to
promote effective condom use using the Cochrane
Infectious Diseases Group’s trials register (Oct 2006),
CENTRAL (Issue 4, 2006), MEDLINE (1966 to Oct 2006),
EMBASE (1974 to Oct 2006), LILACS (1982 to Oct
2006), IBSS (1951 to Oct 2006) and Psychinfo (1996 to
Oct 2006). We extracted data on allocation sequence,
allocation concealment, blinding, loss to follow-up and
measures of effect. Effect estimates were calculated.
Results We identiﬁed 139 trials. Seven out of ten trials
reported reductions in ‘any STI’ with ﬁve statistically
signiﬁcant results. Three out of four trials reported
reductions in pregnancy, although none was statistically
signiﬁcant. Only four trials met all the quality criteria.
Trials reported a median of 11 (IQR 7e17) outcome
measures. Few trials used the same outcome measure.
Altogether, 10 trials (7%) used the outcome ‘any STI’,
4 (3%) self-reported pregnancy and 22 (16%) used
‘condom use at last sex’.
Conclusions The results are generally consistent with
modest beneﬁts but there is considerable potential for
bias due to poor trial quality. Because of the low
proportion of trials using the same outcome the
potential for bias from selective reporting of outcomes
is considerable. Despite the public health importance
of increasing condom use there is little reliable
evidence on the effectiveness of condom promotion
interventions.
INTRODUCTION
Unsafe sex is believed to be the second most
important risk factor for disease, disability or death
in the poorest countries of the world, and the ninth
most important factor in developed countries.
1
Effective condom use has the potential to prevent
sexually transmitted infections (STIs), including
HIV, and unwanted pregnancy.
23However,
condom effectiveness is lower than condom efﬁ-
cacy due to non use, inconsistent use and the
incorrect application of condoms.
45Therefore,
interventions that promote effective condom use
have considerable potential to improve public health.
Interventions to increase effective condom use
have addressed condom design, access to condoms,
condom use behaviours and condom-related legis-
lation. Existing systematic reviews of the effec-
tiveness of interventions to promote effective
condom use have examined speciﬁc population
groups or interventions,
6e8 but to date there has
been no comprehensive systematic review of rand-
omised controlled trials (RCTs) of interventions to
promote effective condom use.
Although systematic reviews of RCTs are
considered to provide the most valid and reliable
evidence of the effectiveness of healthcare inter-
ventions, recent studies have drawn attention to
the effect of trial quality and selective publication
on their results.
9 Selective publication of trials has
been recognised as a potent threat to validity for
many years but more recently the importance of
selective publication of trial outcomes has also been
highlighted.
10e13 We report a systematic review
and methodological appraisal of RCTs of interven-
tions to promote effective condom use.
METHODS
Inclusion criteria
We included all RCTs of interventions to promote
effective condom use regardless of publication
status or language. Participants were men and
women of any age. Interventions were any measure
intended to increase effective condom use. Trials of
female condoms or those comparing latex and non-
latex condoms were excluded because they have
been reviewed previously.
14 Primary outcomes were
the occurrence of pregnancy and STIs. Secondary
outcomes were measures of condom use, including
condom use at ﬁrst sexual intercourse, condom use
at last sexual intercourse, 100% condom use,
frequency of condom use, frequency of unprotected
sex, proportion of episodes of sex protected,
condom use scales and refusal of sexual intercourse
if condom not used. Secondary outcomes for
condom failure outcomes included clinical breakage,
non-clinical breakage and full or partial slippage rates.
Search strategy
We searched the Cochrane Infectious Diseases
Group’s trials register (Oct 2006), CENTRAL (Issue
4, 2006), MEDLINE (1966 to Oct 2006), EMBASE
(1974 to Oct 2006), LILACS (1982 to Oct 2006),
IBSS (1951 to Oct 2006) and Psychinfo (1996 to
Oct 2006) using the search terms condom, contra-
ceptive devices male, condom breakage, slippage
and failure in combination with the Cochrane
collaboration’s search strategy for retrieving trials
(ﬁgure 1).
15 We searched conference proceedings,
contacted researchers and organisations working in
the ﬁeld and checked the reference lists of all iden-
tiﬁed reports. Two reviewers independently scanned
the electronic records to identify potentially trials.
< Additional tables are
published online only. To view
these ﬁles please visit the
journal online (http://jech.bmj.
com).
1Department of Epidemiology
and Population Health, London
School of Hygiene and Tropical
Medicine, London, UK
2University of Cambridge,
Department of Public Health and
Primary Care, Cambridge, UK
Correspondence to
Dr Caroline Free, Nutrition and
Public Health Interventions
Department, Department of
Epidemiology and Population
Health, London School of
Hygiene and Tropical Medicine,
London WC1E 7HT, UK;
caroline.free@lshtm.ac.uk
Accepted 10 May 2009
Published Online First
12 October 2009
This paper is freely available
online under the BMJ Journals
unlocked scheme, see http://
jech.bmj.com/site/about/
unlocked.xhtml
100 J Epidemiol Community Health 2011;65:100e110. doi:10.1136/jech.2008.085456
EssayData extraction
Two reviewers independently extracted data on the generation
of the allocation sequence, allocation concealment, blinding and
loss to follow-up according to the quality criteria developed by
Juni
9 (see key to additional table 1 online for full details). Overall
losses to follow-up of up to 10% were scored adequate. We
extracted data on the measure of effect used in each trial. In
trials that collected short and long-term follow-up data, we
extracted the long-term follow-up data. A reviewer contacted
trial authors asking for all unclear or unreported methods and
data. All discrepancies were agreed by discussion with a third
reviewer. Trials that scored adequate for reporting of all four
quality criteria were categorised as ‘high quality trials’. Data
were extracted regarding whether clustering had been taken into
account in the analysis.
Data analysis and synthesis
All analyses were conducted in STATA version 9.0. We used
funnel plots to explore small study effects. We calculated the log
of the ORs and standard mean differences (SMDs).
16 For the
purposes of meta-analysis, condom use outcomes during vaginal
sexand unspeciﬁedtype of sexwere treated as thesame outcome.
Where two or more intervention arms were compared against
a single control arm and the arms tested similar interventions,
the most intensive intervention (with most components or
longest duration) was included in the analysis. Where two or
more diverse intervention arms were compared against a single
control arm, or a factorial design was used, results are presented
separately.
Poor trial quality is a source of bias so we report the results of
trials that met the four quality criteria (allocation sequence,
allocation concealment, loss to follow-up and blinding of
outcome assessment) separately to other trials. We used random
effects meta-analysis to give pooled estimates.
17 Cluster rando-
mised trial effect estimates were calculated based on the intra-
cluster correlation co-efﬁcient reported or, when not reported,
the lowest of the published intra cluster co-efﬁcient in the
review.
18 We examined heterogeneity visually by examining
forest plots and statistically using the a c
2 test and I2 test for
consistency.
19 We explore the role of study quality via allocation
concealment and inadequate or unclear blinding as these
elements of study quality have been shown to inﬂuence outcomes
reported.
9
RESULTS
The combined search strategies identiﬁed 622 electronic records.
These were screened for eligibility and the full texts of 269
potentially eligible reports were obtained for further assessment.
Out of the 269 potentially eligible reports, 138 reports
containing 139 RCTs met the study inclusion criteria (ﬁgure 2).
See additional table 1 online for a short description of all studies
and the results of the quality assessment.
Figure 1 Search strategy. Search
set
COCHRANE 
CENTRAL MEDLINE EMBASE LILACS IBSS
1  Condom* ti, ab  Condom*  ti, ab  Condom$ ti, 
ab Condom$  Condom* 
2 Condoms  [Mesh]  Condoms  [Mesh]  Condom 
[Emtree] 
Randomized 
controlled 
trial$  
Randomized 
controlled 
trial* 
3 Contraceptive 
devices, male [Mesh] 
Contraceptive 
devices, male [Mesh]  1 or 2 
Controlled 
clinical 
trial$  
Controlled 
clinical 
trial* 
4  1 or 2 or 3  1 or 2 or 3 
Randomized 
controlled 
trial$  
Random$ Random*   
5 Randomized 
controlled trial  [pt] 
Controlled 
clinical trial$  
(double 
blind$) OR 
(single
blind$) Or 
(triple 
blind$)  
(double 
blind*) OR 
(single 
blind*) Or 
(triple blind) 
6 Controlled clinical 
trial [pt]  Random$ 
Crossover 
OR cross-
over  
Crossover 
OR cross-
over  
7    Random* ti, ab 
(double 
blind$) OR 
(single blind$) 
Or (triple 
blind$)  
2 or 3 or 4 
or 5 or 6 
2 or 3 or 4 
or 5 or 6 
8
(double blind*) OR 
(single blind*) Or 
(triple blind*) ti, ab 
Crossover OR 
cross-over   1 and  7  1 and  7 
9 Crossover OR cross-
over ti, ab 
4 or 5 or 6 or 7 
or 8 
10    5 or 6 or 7 or 8 or 9  3 and 9     
11    4 and 10   Limit 10 to 
Humans 
12     Limit 12 to Human       
13        
We also searched the Cochrane Infectious Diseases Group Specialised register
3 using the term 'condom*'.
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EssayCharacteristics of studies
The 139 trials included approximately 143000 participants. Of
the 139 trials, one used a crossover design, 32 were cluster
randomised trials and one used a factorial design. Altogether, 21
of the 32 cluster randomised trials reported having adjusted the
results for clustering. Trial participants were recruited from
several different settings, including healthcare (57 trials),
education (28 trials), community (43 trials), military (1 trial)
and unspeciﬁed (10 trials). Thirty-three trials had two or more
intervention arms. The target populations were young people
(48 trials), people with an STI (26 trials), intravenous drug users
(19 trials), men who have sex with men (15 trials), other high
risk individuals (17 trials), psychiatric patients (5 trials) and
unspeciﬁed (15 trials). Altogether, 13 trials recruited participants
from speciﬁc ethnic groups; the other 126 trials did not specify
the ethnicity of participants. The median interval between
randomisation and last outcome measurement was 26 weeks
(IQR 13e52).
Interventions
The trials evaluated 181 different interventions. These were
individual sexual behaviour change (n¼156), sexual and intra-
venous drug behavioural change (n¼19) and condom design
(n¼6). There were 23 simple interventions (with one or two
components) and 158 complex interventions (with three or
more components). The sexual behaviour change interventions
addressed information, attitudes, condom use skills and/or
condom availability, interpersonal factors within the sexual
relationship inﬂuencing condom use and social factors
inﬂuencing sex and condom use (see additional table 2 online).
Sexual and intravenous drug behaviour interventions addressed
safer injecting behaviour (15 trials), links between substance use
and condom use (11 trials), substance use reduction (12 trials)
and detoxiﬁcation treatment (1 trial). Condom design trial
interventions included providing a choice of condoms of
different designs, different standards for manufacture
of condoms, thicker/thinner condoms and different shapes of
condom (baggy/straight shafted).
Outcomes and reporting bias
The trials included 90 different STI, pregnancy or condom use
outcome measures. Trials reported between 1 and 49 outcomes
per trial (median 11; IQR 7e17). Among the outcome measures
used most frequently, 10 trials (7%) used the outcome ‘any STI’,
4 (3%) self-reported pregnancy and 22 (16%) used ‘condom use
at last sex’.
Few trials used objective measures. Only 21(15%) trials
reported a pregnancy or objective STI outcome measure. One
trial used an objective measure of condom use.
Fifty-two trials did not provide enough data to calculate effect
estimates so it was only possible to calculate effect estimates for
63% (n¼87) of the trials.
Figure 2 Associations of the effects of behavioural
interventions on primary outcomes sexually transmitted
infection (STI) and self-reported pregnancy. Odds ratio (95%CI)
Boyer et al 200520 0.64 ( 0.43, 0.95)
Boyer et al 199721 1.57 ( 0.66, 3.72)
Carey et al 200422 1.69 ( 0.55, 5.20)
Downs et al 200423 0.74 ( 0.25, 2.14)
Imrie et al 200124 1.69 ( 1.03, 2.77)
Jemmott et al 200525 0.58 ( 0.33, 1.02)
Kamb et al 199826
0.76 ( 0.61, 0.94)
NIMH 199827
0.73 ( 0.63, 0.84)
O'Donnell et al 199828
0.80 ( 0.65, 0.98)
Shain et al1999 & 200229,30
0.54 ( 0.36, 0.82)
OR (95%  CIS)*
OR (95%  CIS)*
5 1 5 2 .
DiClemente et al 200431 0.70 ( 0.34, 1.44)
Philliber et al 200232
0.57 ( 0.26, 1.27)
Study
Study
Odds ratio (95% CI)
3.50 1 .25
Shlay et al 200333 0.81 ( 0.60, 1.09)
Wight et al 200234 1.05 ( 0.31, 3.50)
a
b
A. Outcome: any STI. B. Outcome: self-reported pregnancy. 
*Studies are coded such that an increased OR depicts an increased risk of outcome.
I2 values for variation in ORs attributable to heterogeneity were 64% for STI outcomes
and 0% for self-reported pregnancy.
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EssayStudy quality
Only four trials scored adequate for reporting of all four quality
criteria (allocation sequence, allocation concealment, loss to
follow-up and blinding).
31 35e37 The generation of the allocation
sequence was adequate in 54 trials (39%), allocation conceal-
ment was adequate in 32 trials (23 %), losses to follow-up were
adequate in 24 trials (17%) and outcome assessment was blinded
in 34 trials (24%).
Effectiveness
For each type of interventiondsexual behaviour change inter-
ventions, sexual and intravenous drug behaviour change
interventions and condom design interventionsdwe report the
primary (pregnancy and STI) and secondary (condom use)
outcomes. The results of high-quality trials are presented ﬁrst
followed by the results of other trials.
Sexual behaviour change interventions
Primary outcomes: pregnancy and STI
High-quality trial results. There was one trial which met all four
quality criteria. Feldblum et al’s trial evaluated peer education
combined with individual risk counselling by a clinician among
sex workers in Madagascar and reported a reduction in self-
reported sexually transmitted disease symptoms OR¼0.67
(0.51e0.89).
35
Other trial results. Figure 3 shows forest plots for the effect of
complex sexual behaviour change interventions on primary
outcome measures. Three of the four trials reporting results
regarding self-reported pregnancy had fewer pregnancies in the
intervention group but no results were statistically signiﬁcant.
In 7 of the 10 trials reporting the outcome ‘any STI’ there were
fewer STIs in the intervention group with ﬁve statistically
signiﬁcant results. One trial reported a statistically signiﬁcant
increase in ‘any STI’. Table 1 shows the effect estimates for trials
reporting other STI outcomes. In 10 out of the 16 reported
outcomes there were fewer STIs in the intervention group with
three statistically signiﬁcant results. One trial reported a statis-
tically signiﬁcant reduction in gonorrhoea and a statistically
signiﬁcant increase in syphilis.
42
Exploring heterogeneity in STI outcomes according to study quality.
Pooled estimates for the outcome ‘any STI’ 0.79 (95% CI 0.66 to
0.94) showed considerable heterogeneity (I
2 64%, p¼0.003). The
pooled OR for ‘any STI’ among trials with adequate allocation
Boekeloo et al 1999
46
Borgia et al 2005
47
Branson et al 1998
36
Bryan et al 1996
48
DiClemente et al 2004
31
Study ID
) 5 1 . 3   , 5 3 . 0 (   5 0 . 1
) 2 3 . 1   , 5 8 . 0 (   6 0 . 1
) 0 4 . 1   , 7 6 . 0 (   7 9 . 0
) 1 3 . 5   , 9 8 . 0 (   8 1 . 2
) 6 2 3 0 5 1 ( 1 2 2
) I C   % 5 9 (   R O
x e s   ) d e i f i c e p s n u   r o (   l a n i g a v   t s a l   t a   e s u   m o d n o C
) 9 3 . 2   , 1 0 . 0 (   2 1 . 0
) 6 5 . 1   , 5 9 . 0 (   2 2 . 1
) 3 9 4 8 9 0 ( 0 2 2
) 1 7 . 2   , 7 9 . 0 (   2 6 . 1
x e s   ) d e i f i c e p s n u   r o (   l a n i g a v   g n i r u d   e s u   m o d n o c   % 0 0 1
) I C   % 5 9 (   R O D I   y d u t S
Fitzgerald et al 1999
49
Kirby et al 1997
50
Kvalem et al 1996
51
Philliber et al 2002
32
Shrier et al 2001
52
Stanton et al 2006
53
Stanton et al 1998
54
Stanton et al 1998
55
Weeks et al1997
56
2. 1 21 ( . 0 5 , 3. ) 6 2
) 1 9 . 2   , 4 3 . 1 (   8 9 . 1
) 8 1 . 1   , 9 4 . 0 (   6 7 . 0
) 1 9 . 2   , 7 7 . 0 (   0 5 . 1
) 5 0 . 2   , 6 7 . 0 (   5 2 . 1
) 0 6 . 3   , 9 4 . 0 (   3 3 . 1
) 1 0 . 1   , 0 5 . 0 (   1 7 . 0
) 7 9 . 1   , 9 7 . 0 (   4 2 . 1
) 1 0 . 4   , 4 6 . 0 (   1 6 . 1
) 4 8 . 1   , 5 5 . 0 (   0 0 . 1
  1 9 . 0 ( 3 5 . 0 , 8 5 . 1   )
2. 0 20 ( . 8 9 , 4. ) 3 9
) 2 4 . 2   , 6 1 . 1 (   7 6 . 1
) 5 8 . 1   , 1 8 . 0 (   2 2 . 1
) 7 0 . 4   , 2 6 . 0 (   9 5 . 1
) 8 8 . 5   , 6 7 . 0 (   2 1 . 2
) 1 7 . 1   , 8 1 . 0 (   6 5 . 0
) 8 2 . 4   , 8 4 . 0 (   4 4 . 1
) 8 1 . 3   , 6 2 . 0 (   1 9 . 0
  5 1 . 1 ( 9 8 . 0 , 8 4 . 1   ) Wenger et al 1992
57
Wight et al 2002 (men)
34
Wight et al 2002 (women)
34
Xu et al 2002
58
) , (
) 6 2 . 2   , 0 5 . 0 (   6 0 . 1
) 6 7 . 1   , 3 5 . 0 (   7 9 . 0
) 5 4 . 2   , 2 9 . 0 (   0 5 . 1
* ) s l a v r e t n i   e c n e d i f n o c   % 5 9 (   o i t a r   s d d O
1 5 3 . 0 0 5 . 5
Amirkhanian et al 2005
59
Balmer et al 1998
60
Boyer et al 2005
20
Cleary et al 1995
61
DiClemente et al 2004
31
Fogarty et al 2001 & Geilen et al 2001
62,63
Jemmott et al 1998
64
Kely et al 1997 Psychiatr serv
65
Kuchaisit and Higginbotham 1996
66
Mansfield et al 1993
67
Orr et al 1996
68
Scholes et al 2003
69
The Voluntary HIV-1 Counseling and
 
Wu et al 2003
71
) , (
) 8 0 . 1   , 9 7 . 0 (   2 9 . 0
) 6 5 . 1   , 3 6 . 0 (   9 9 . 0
0 0 . 4 0 0 . 2 0 0 . 1 0 5 . 0 5 2 . 0 0 1 . 0
* ) s l a v r e t n i   e c n e d i f n o c   % 5 9 (   o i t a r   s d d O
% i t b ) d i f i ( l i i d d % 0 0 1
) I C   % 5 9 (   R O D I   y d u t S
Amirkhanian et al 2005
59
Choi et al 1996
72
) 5 5 . 2   , 2 9 . 0 (   3 5 . 1
) 3 2 . 2   , 4 7 . 0 (   9 2 . 1
) 1 8 . 4   , 8 8 . 0 (   6 0 . 2
) I C   % 5 9 (   R O D I   y d u t S
0 0 1 % e s   l a n a   g n i r u d   e s u   m o d n o c   x % 0 0 1 n o c   d   e s u   m o d r u i g a v   g n i a n l( c e p s n u   r o i f i e ) d a   r o   x e s   bs i t e c n e n
) 7 8 . 4   , 2 9 . 0 (   2 1 . 2
Cleary et al 1995
61
Imrie et al 2001
24
Kely et al 1997 Lancet
73
Roffman et al 1997
74
Rosser 2002
75
Tudiver et al 1992
76
) 2 3 . 4   , 3 5 . 1 (   8 5 . 2
) 7 3 . 5   , 7 7 . 1 (   8 0 . 3
) 2 9 . 2   , 8 0 . 1 (   7 7 . 1
) 4 2 . 0 1   , 9 0 . 1 (   3 3 . 3
) 4 0 . 1   , 7 2 . 0 (   3 5 . 0
Jemmott et al 1998
64
8
27 9 9 1   H M I N
Rotheram-borus
 et al 2004
77
) 2 0 . 2   , 6 4 . 0 (   7 9 . 0
) 0 7 . 1   , 6 2 . 1 (   6 4 . 1
4 0 0 1 0 5
* ) s l a v r e t n i   e c n e d i f n o c   % 5 9 (   o i t a r   s d d O
* ) s l a v r e t n i   e c n e d i f n o c   % 5 9 (   o i t a r   s d d O 0 1 4 2 1 5 . 0 5 2 . 0
0.4 1.0 5.0
*Studies are coded such that an increased OR depicts an increased occurrence of protected sex implying a positive outcome from the intervention. I2 values for
variation in ORs attributable to heterogeneity were 53% condom use at last sex, 35.5% for 100% condom use, 66.8% for 100% condom use during anal
sex and 0% for 100% condom use or abstinence.
Testing Efficacy Study Group 2002
70
Figure 3 Associations of the effects of behavioural interventions on secondary binary outcomes measuring condom use during sex.
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Essayconcealment was 0.98 (95% CI 0.64 to 1.52; I
2 75.9%; p¼0.006)
and for trials with inadequate or unclear allocation concealment
was 0.73 (95% CI 0.64 to 0.83; I
2 9.8%; p¼0.353). The pooled
OR for ‘any STI’ among trials with adequate blinding of the
outcome assessor was 0.83 (95% CI 0.62 to 1.10; I
2 73.4%;
p¼0.01) and for trials with inadequate or unclear blinding was
0.76 (95% CI 0.58 to 0.99; I
2 39.1%; p¼0.145).
Secondary outcomes: condom use
High-quality trial results. There were two trials that met all four
quality criteria. Egger et al used an objective measure of condom
use (ﬁnding a used condom in the motel room bin).
44 They
found that giving out condoms and providing condoms in motel
rooms used for commercial sex increased condom use compared
to having condoms available on request from reception (OR
1.32, 95% CI 1.03 to 1.61 and OR 1.31, 1.09 to 1.75, respectively.
In motel rooms used for non-commercial sex, the same strategies
also increased condom use for handing out condoms (OR 1.81,
95% CI 1.14 to 2.81) and for having condoms in motel rooms
(OR 1.52, 95% CI 1.01 to 2.38). Providing health educational
materials reduced condom use in commercial sex compared to
when health educational materials were not provided (OR 0.89,
95% CI 0.84 to 0.94).
44 Ehrhardt et al evaluated small group
gender-speciﬁc discussion and used self-reported outcomes of
either maintaining or improving safe sex (OR 1.64, 95% CI 0.95
to 2.86).
45
Other trial results. Figures 4 and 5 and table 2 show the effect
estimates for trials for each measure of condom use. For condom
use at last sex, 9 of the 18 trials reported increases in condom use
with two statistically signiﬁcant results. For 100% condom use in
vaginal (or unspeciﬁed) sex, 9 of the 14 trials reported increases in
condom use although none was statistically signiﬁcant. For
100% condom use for anal sex, seven of the eight trials reported
increases in condom use with three statistically signiﬁcant
results. Two out of three trials reported increases in 100%
condom use or abstinence with one statistically signiﬁcant result.
No trials reported increases in the frequency of protected
sex. Three out of six trials reported statistically signiﬁcant
increases in the proportion of sex protected. For outcomes using
condom use scales, two out of four trials reported increases in
condom use of which one was statistically signiﬁcant. One of
three trials reported a statistically signiﬁcant increase in the
frequency of condom use. In 16 of the 22 other condom
use outcomes reported, there was more condom use in the
intervention group with eight showing statistical signiﬁcance
(table 2).
Sexual and intravenous drug behaviour change interventions
Primary outcomes: pregnancy and STI
High-quality trial results. There were no trials of sexual and
intravenous drug behaviour change interventions that met all
four quality criteria.
Other trial results. The Iguchi 1996 trial
95 compared a 90-day drug
detoxiﬁcation programme to a 21-day drug detoxiﬁcation
programme and reported an OR consistent with a reduction in
HIV acquisition (OR 0.37, 95% CI 0.11 to 1.28) (table 3).
Secondary outcomes: condom use
High-quality trial results. There were no trials of sexual and
intravenous drug behaviour change interventions reporting
condom use outcomes that met all four quality criteria.
Other trial results. In 9 of the 13 condom use outcomes reported
there was more condom use in the intervention group with
three showing statistical signiﬁcance (table 3).
Condom design interventions
Primary outcomes: pregnancy and STI
There were no trials of condom design interventions reporting
primary (pregnancy or STI) outcomes.
Secondary outcomes: condom use
High-quality trial results. Golombok et al compared thicker
condoms to thinner condoms and found that there was no
difference in condom failure before or during sex (OR 1.06, 95%
CI 0.79 to 1.41) (table 4).
103
Other trial results. The Steiner 2006 trial compared providing
participants with a choice of different types of condom to
providing one type of condom and reported a OR consistent
with an increase in acquisition of ‘any STI’ (OR 1.31, 95% CI
0.80 to 2.15) for the ‘choice of condom’ arm.
104 The Benton 1997
trial
105 reported that Swiss quality seal standard condoms were
less likely to break during anal sex than Australian standard
condoms, and the Renzi 2003 trial
106 of the reality female
condom for anal sex reported this was less likely to slip during
anal sex than a standard condom (table 4).
DISCUSSION
Summary of ﬁndings
This review included over 143000 study participants from 139
trials promoting effective condom use. Despite these research
efforts, this review cannot provide reliable estimates of the
effectiveness of interventions in promoting condom use due to
the high potential for bias in the effect estimates.
Table 1 Primary outcomes for sexual behaviour change interventions
Study Outcome
OR/RR/SMD
(95% CI)
High-quality trials
Feldblum
35 STD symptoms OR 0.67 (0.51 to 0.89)
Other trials
Branson
36 Gonorrhoea OR 0.92 (0.64 to 1.32)
Branson
36 Syphillis OR 1.80 (0.61 to 5.32)
Branson
36 Chlamydia OR 0.90 (0.60 to 1.36)
Cohen 1992
37 (condom
skills)
Reinfection with STI OR 0.57 (0.34 to 0.96)
Cohen 1992
37
(condom distribution)
Reinfection with STI OR 0.91 (0.58 to 1.44)
Cohen 1992
37
(condom social inﬂuences)
Reinfection with STI OR 0.97 (0.60 to 1.56)
Diclemente
38 Chlamydia OR 0.17 (0.03 to 0.09)*
Explore
39 HIV OR 0.79 (0.61 to 1.02)
Gollub
40 Probable STI OR 1.09 (0.60 to 1.99)
Harvey
41 Treated for STD in last
6 months
OR 0.96 (0.74 to 1.23)
Kamali
42 HIV rate (PY) RR 1.00 (0.87 to 1.16)
Kamali
42 Gonorrhoea rate (PY) RR 0.43 (0.32 to 0.59)
Kamali
42 Chlamydia rate (PY) RR 1.06 (0.88 to 1.27)
Kamali
42 CHSV2 rate (PY) RR 1.04 (0.93 to 1.17)
Kamali
42 Active syphilis rate (PY) RR 7.01 (5.82 to 8.51)
Shain
43 Chlamydia or gonorrhoea OR 0.8 (0.55 to 1.16)
Results in italics are for studies with factorial design or those where more than one
comparison group tested against a single control has been included.
*These are the results reported in the paper, which adjusted for baseline variables and
covariates.
PY, per year; STD, sexually transmitted disease; STI, sexually transmitted infection.
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EssayThe potential for bias is high for three main reasons. First,
trials were of low quality and only four trials met all the quality
criteria. Effect estimates have been found to be higher in lower
quality studies where there is no allocation concealment and the
results of our subgroup analysis according to allocation
concealment are consistent with this.
9 Second, most trials
relied only on self-reported condom use outcomes (85%). Only
one of the trials meeting all four quality criteria also used an
objective outcome measure. Third, a low proportion of trials
reported data using the same outcomes measure. Among the
most commonly used outcomes, only 10 trials (7%) reported
data regarding the outcome ‘any STI’, 4 (3%) reported outcome
data for pregnancy and 22 (16%) reported outcome data for
‘condom use at last sex’. This is likely to have resulted in an
overestimate of effects due to selective reporting of outcomes
where statistically signiﬁcant beneﬁt is found. Thus, while the
results reported in the trials in this review are generally consis-
tent with modest beneﬁts, the effect estimates cannot be
considered reliable.
In the entire review there was only one trial that met all
the quality criteria and used a single objective condom use
outcome measure.
35 Furthermore, the intervention was unique
and, thus, there is no potential for selective reporting of
outcomes in other similar trials. This trial demonstrated that
either giving condoms to clients in motels or providing them in
motel rooms was effective in increasing condom use for
commercial and non-commercial sex.
Strengths and limitations of the review
This is the ﬁrst comprehensive systematic review and method-
ological appraisal of all interventions promoting effective
condom use. Descriptions of the intervention components are
limited as these were based on the trial reports, which varied
considerably in detail. Our analysis of trial quality as a source of
heterogeneity, according to blinding and allocation concealment,
for the outcome ‘any STI’ has limited power as few trials
contributed to this pooled analysis. The heterogeneity of effect
estimates means it is more appropriate to view individual study
results; pooled estimates according to study quality are
presented to show that these ﬁndings are consistent with earlier
studies.
9 We had insufﬁcient power to explore any other aspects
of trial quality as sources of heterogeneity. Among the trials
reporting an increase in ‘any STI’, both the Imrie et al
24 and
Boyer et al
21 trials had adequate allocation concealment. Other
potential sources of heterogeneity include the type of partici-
pants and features of the intervention such as the duration,
components and educational media used in the interventions.
For example, among the trials reporting an increase in ‘any STI’,
Imrie et al recruited men who deﬁned themselves as ‘gay’
24 and
Carey et al recruited patients attending outpatient psychiatric
care.
22 Imrie et al’s intervention was the only trial that was
a single session intervention.
24 Many of the components
addressed in trials of interventions reporting increases
in ‘any STI’ were similar to those addressed in the interventions
reporting beneﬁcial effects (eg, information, attitudes, self-
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I2 values for variation in SMD attributable to heterogeneity were 0% for frequency of unprotected sex, 95.5% for proportion of unprotected sex, 80.7% for condom use scales and
95.1% for frequency of condom use.
Figure 4 Associations of the effects of behavioural interventions on continuous secondary outcomes looking at frequency or proportion of
unprotected sex or condom use.
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Essayefﬁcacy, condom use skills, condom negotiation skills, motiva-
tion),
21 22 24 but Imrie et al’s intervention did not involve
personal risk assessment, which was addressed by ﬁve of the
trials reporting beneﬁcial effects.
24 The interventions also used
different educational methods. For example, neither Imrie et al
nor Carey et al used videos, which were used in six of the
interventions reporting beneﬁcial effects.
22 24 We did not have
sufﬁcient power to robustly explore the type of participants and
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Table 2 Secondary outcomes for sexual behaviour change interventions
Study Outcome OR/SMD (95% CI)
High quality trials
Egger
44 (condom in room commercial sex hotel) Retrieval of at least one condom OR 1.31 (1.09 to 1.75)
Egger
44 (condom handed to client commercial sex hotel) Retrieval of at least one condom OR 1.32 (1.03 to 1.61)
Egger
44 (condom in room, non-commercial sex hotel) Retrieval of at least one condom OR 181 (1.14 to 2.81)
Egger
44 (condom handed to client non-commercial sex
hotel)
Retrieval of at least one condom OR 1.52 (1.01 to 2.38)
Egger
44 (leaﬂet, commercial sex workers) Retrieval of at least one condom OR 0.89 (0.84 to 0.94)
Egger
44 (leaﬂet non-commercial sex workers) Retrieval of at least one condom OR 1.03 (0.97 to 1.08)
Ehrhardt
30 Maintaining/improving safe-sex (women) OR 1.64 (0.95 to 2.86)
Other trials
Bellingham
89 Condom use at last sex (vaginal or unspeciﬁed) OR 0.58 (0.31 to 1.12)
Downs
23 Number of condom failures (over period $3 months) SMD  0.25 ( 0.55 to 0.06)
Downs
23 Consistency of condom use with partners SMD 0.14 ( 0.14 to 0.43)
Downs
23 Number of condom failures SMD  0.25 ( 0.55 to 0.06)
Hobfoll
88 Condom use scale (never e always) anal sex SMD 0.316 ( 0.034 to 0.67)
Jemmot
25 Number of days had unprotected sex in last year SMD  4.42 ( 4.89 to  3.95)
Kalichman
80 No condom, no sex (vaginal or unspeciﬁed) OR 1.90 (0.74 to 4.88)
Kalichman
80 Condom use over 50% of the time OR 2.36 (0.92 to 6.01)
Picciano
90 Frequency of condom use (oral sex) SMD 0.062 ( 0.35 to 0.48)
Robert
91 (eroticising safer sex) 100% condom use or abstinence (anal sex) OR 0.42 (0.10 to 1.89)
Robert
91 (Stop AIDS Programme) 100% condom use or abstinence (anal sex) OR 0.96 (0.18 to 5.22)
Roffman
74 Proportion of oral sex protected SMD 0.02 ( 0.21 to 0.25)
Roffman
74 Proportion of anal sex protected SMD 0.28 (0.05 to 0.52)
Rosser
75 Change in unsafe anal sex SMD  0.20 ( 0.51 to 0.11)
Rosser
75 Change in failure to use condoms SMD  0.79 ( 1.35 to  0.23)
Stephenson
92 Unprotected ﬁrst sex by age 16 y OR 0.89 (0.24 to 3.31)
Shain 1999 and 2002
29 <5 episodes of unsafe sex in last 3 months OR 2.09 (1.44 to 3.05)
Shlay
33 Condom use over 50% of the time OR 1.14 (0.82 to 1.57)
Swanson
93 Percentage of time condoms used to prevent herpes SMD 0.28 (0.01 to 0.54)
The Voluntary HIV Testing Study
70 100% protected sex with non-primary partner OR 1.32 (0.98 to 1.78)
Tripiboon
94 Condom use score (for married couples) SMD 11.04 (10.14 to 11.94)
Wenger
57 No condom, no sex (unspeciﬁed or vaginal) OR 2.55 (1.19 to 5.45)
Results in italics are for trials with a factorial design or trials where the results of more than one comparison group tested against a singe control group are reported.
All secondary outcomes reported in this table are used in less than three other trials of this type of intervention.
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Essaythe duration, components and educational media used in the
interventions as sources of heterogeneity in this systematic
review.
Sources of bias in the systematic review
First, low trial quality in this review is an important potential
source of bias. Effect estimates have been found to be higher
where there is no allocation concealment and the results of our
subgroup analysis according to allocation concealment are
consistent with this.
9 Second, the use of self-reported condom
use outcomes is likely to have resulted in bias. Interventions
promoting sexual behaviour change may inﬂuence reporting
regarding behaviour more than actual behaviour and where
participants are not blind to the intervention there may be
Table 4 Primary and secondary outcomes for condom design interventions
Study Type of intervention Outcome
OR
(95% CI)
High quality trials
Golombok
103 Thicker vs thinner condom Condom failure before/during sex OR 1.06 (0.79 to 1.41)
Golombok
103 Thicker vs thinner condom Condom failure during sex OR 1.01 (0.70 to 1.47)
Golombok
103 Thicker vs thinner condom Condom breakage before or during sex OR 1.02 (0.66 to 1.58)
Golombok
103 Thicker vs thinner condom Condom breakage during sex (over
speciﬁed time period)
OR 0.94 (0.49 to 1.80)
Golombok
103 Thicker vs thinner condom Full slippage during sex OR 1.01 (0.70 to 1.47)
Golombok
103 Thicker vs thinner condom Partial slippage during sex OR 1.06 (0.64 to 1.76)
Other trials
Primary outcomes
Steiner
104 Choice of condoms Any STI OR 1.31 (0.80 to 2.15)
Secondary condom use outcomes
Joanis (C Joanis, M Weaver, C Toroitich-
Ruto, et al, unpublished)
Choice of condoms Proportion of sex protected SMD  0.135 ( 0.250 to  0.020)
Steiner
104 Choice of condom Proportion of sex protected SMD 0.110 ( 0.082 to 0.303)
Benton
105 Swiss quality seal: Australian standard
condom
Condom breakage during sex OR 0.86 (0.49 to 1.49)
Benton
105 Swiss quality seal: Australian standard
condom
Condom breakage during vaginal sex OR 1.37 (0.65 to 2.89)
Benton
105 Swiss quality seal: Australian standard
condom
Condom breakage during anal sex OR 0.20 (0.04 to 0.92)
Renzi
106 Baggy condom: straight shafted condom Condom breakage during sex (over
speciﬁed time period)
OR 1.34 (0.46 to 3.89)
Renzi
106 Baggy condom: straight shafted condom Slippage during sex OR 0.85 (0.57 to 1.26)
Renzi
106 Female reality condom for anal sex Breakage reported by men (receptive
partners)
OR 1.71 (0.74 to 3.96)
Macaluso
107 Female reality condom for anal sex Slippage reported by men (receptive
partners)
OR 2.68 (1.92 to 3.75)
Macaluso
107 Female reality condom for anal sex Slippage reported by men (insertive
partner)
OR 34.10 (18.97 to 61.27)
Table 3 Primary and secondary outcomes for sexual and intravenous drug behaviour change interventions
Study Outcome
OR or SMD
(95% CI)
Primary outcomes
Iguchi
95 Acquisition of HIV OR 0.37 (0.11 to 1.28)
Secondary outcomes
Avants
96 Number of weeks had sex without a condom SMD  0.326 ( 0.594 to  0.059)
Cottler
97 No sex if no condom OR 0.99 (0.70 to 1.40)
Cottler
97 Used a condom in the last 30 days OR 1.01 (0.74 to 1.36)
Cottler
97 ‘Improved’ condom use OR 1.31 (0.98 to 1.77)
Eldridge
98 Log mean proportion of vaginal sex protected SMD 0.925 (0.356 to 1.494)
Kotranski
99 100% condom use or abstinence (vaginal or unspeciﬁed) OR 1.50 (1.02 to 2.22)
Cottler
97 100% condom use (vaginal or unspeciﬁed) OR 0.95 (0.66 to 1.37)
Margolin
100 100% condom use (vaginal or unspeciﬁed) OR 3.94 (0.94 to 16.58)
Hershberger
101 100% condom use (vaginal or unspeciﬁed) OR 2.43 (1.37 to 4.32)
Hershberger
101 Proportion of sex protected (vaginal or unspeciﬁed) SMD 0.08 ( 0.07 to 0.22)
Iguchi
95 Improvement in condom use (dichotomous) OR 1.03 (0.76 to 1.40)
Sorensen
102 (maintenance group) Proportion of sex protected (vaginal or unspeciﬁed) SMD 0.661 ( 0.397 to 1.718)
Sorensen
102 (detoxiﬁcation group) Proportion of sex protected (vaginal or unspeciﬁed) SMD 0.031 ( 0.737 to 0.800)
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Essaydifferential misreporting of outcomes between the intervention
and control group. Third, a low proportion of trials reported
sufﬁcient data to calculate effect estimates using the same
outcome measures. Of the most commonly reported outcomes,
only ten trials (10%) reported data regarding the outcome ‘any
STI’, four (4%) reported the outcome ‘pregnancy’ and 22 (16%)
reported condom use at last sex outcomes. Furukawa et al
conducted an analysis of Cochrane reviews in which a median of
46% of trials (IQR 20e75%) reported sufﬁcient data to calculate
effect estimates using the same outcome.
13 They found that in
systematic reviews where a low proportion of trials used the
same outcomes the effect estimates were higher than in
systematic reviews where a high proportion of trials used the
same outcomes. This is caused by selective reporting of
outcomes in trials where no statistically signiﬁcant beneﬁti s
found.
13 Therefore, the low proportion of trials using the same
outcome measures in this systematic review is likely to have
resulted in an over-estimate of effect estimates.
Implications for research
Standards of conduct and reporting for trials promoting effective
condom use must urgently be agreed. Consensus must be
reached regarding which outcomes must be included irrespective
of other reported outcomes. All future trials must include an
objective measure of STI or pregnancy so that the trial results
can be meaningfully compared and, where relevant, can
contribute to future meta-analyses of objective biological
outcomes. The components of interventions should be clearly
described within trial reports. Trial protocols must be registered
in advance with clearly speciﬁed outcomes. Trials promoting
effective condom use should follow the existing guidance for the
reporting and conduct of RCTS.
108
Implications for condom promotion interventions
Condom distribution proximal to the time of sex has been
shown to increase condom use in one high-quality trial in one
setting. Innovative alternate means of distributing condoms
proximal to the time of sex, especially among high-risk groups,
should be evaluated. A high-quality trial of the female reality
condom for anal sex should be conducted as results from a low-
quality trial suggest the female reality condom may be less likely
to slip than a standard condom. Future sexual behaviour change
interventions should be based on the content of existing
interventions that report beneﬁcial effects. Such interventions
should be evaluated by an adequately powered high-quality RCT.
Conclusion
Increasing effective condom use is of global public health
signiﬁcance. Reported results in the trials in this review are
generally consistent with modest beneﬁts, but bias introduced
by the poor quality of trials, reliance on self-reported outcomes
and selective reporting of outcomes mean that the reported
results are likely to be an over-estimate of effects. Robust
conclusions regarding the effectiveness of interventions
promoting effective condom use cannot be made. Future trials
promoting effective condom use must be conducted and
reported to the highest standards.
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